Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03735589||Not yet recruiting||Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer||
||Other / NIH||
||18||Female||18 Years and older (Adult, Older Adult)||NCT03735589||i 60417
|February 15, 2019||May 3, 2020||May 3, 2021||November 8, 2018||January 25, 2019||